HM-30181

Known as: HM30181 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2014
01220062014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The breast cancer resistance protein (BCRP, ABCG2) belongs to the superfamily of ATP binding-cassette (ABC) proteins. In addition… (More)
Is this relevant?
2014
2014
Eribulin mesylate was developed as a potent microtubule-targeting cytotoxic agent to treat taxane-resistant cancers, but recent… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
AIMS HM30181 is a third generation P-glycoprotein (P-gp) inhibitor currently under development. The objectives of this study were… (More)
Is this relevant?
2013
2013
HM30181 is a new P-glycoprotein (P-gp) inhibitor. This study was conducted to investigate the effect of HM30181 and its duration… (More)
Is this relevant?
2012
2012
HM30181, a potent and selective inhibitor of the adenosine triphosphate-binding cassette transporter P-glycoprotein (Pgp), was… (More)
Is this relevant?
2012
2012
BACKGROUND HM30181 is an oral P-glycoprotein (P-gp) inhibitor developed to enhance the oral bioavailability of P-gp substrate… (More)
  • table I
  • table II
  • table III
  • figure 1
  • figure 2
Is this relevant?
2010
2010
Multi-drug resistance 1 (MDR1, ABCB1), also known as P-glycoprotein (P-gp), restricts intestinal uptake of many drugs, and… (More)
Is this relevant?
2007
2007
HM-30181, 4-oxo-4H-chromene-2-carboxylic acid [2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H… (More)
Is this relevant?
2006
2006
An LC-MS/MS method for the simultaneous determination of a new P-glycoprotein inhibitor 4-oxo-4H-chromene-2-carboxylic acid [2-(2… (More)
Is this relevant?
2006
2006
HM-30181, 4-oxo-4H-chromene-2-carboxylic acid, [2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H… (More)
Is this relevant?